A Study of S5G4T-1 in the Treatment of Papularpustular Rosacea

Status Completed

Clinical Trial Summary

To assess the efficacy and safety of S5G4T-1 compared to S5G4T-1 vehicle when applied once daily for 12 weeks in participants with papulopustular rosacea.

Clinical Trial Description

In this Phase 3, double-blind, randomized, vehicle-controlled, parallel-group pivotal study, participants will be admitted only after a written informed consent has been obtained and after all inclusion/exclusion criteria have been met. Male and female participants at least 18 years of age with moderate or severe papulopustular rosacea will be eligible for enrollment for daily treatment with S5G4T-1 or its vehicle for 12 weeks. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03564119
Study type	Interventional
Source	Sol-Gel Technologies, Ltd.
Contact
Status	Completed
Phase	Phase 3
Start date	June 21, 2018
Completion date	June 10, 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03276936` - A Study to Evaluate the Long-Term Safety of Topical Administration of FMX103 in the Treatment of Moderate to Severe Papulopustular Rosacea	Phase 3
Completed	`NCT02601963` - Safety and Efficacy Study of a Topical Minocycline Foam in Patients With Papulopustular Rosacea	Phase 2
Completed	`NCT02268474` - Excel V 532 nm KTP Laser for Treatment of Erythematotelangiectatic Rosacea & Papulopustular Rosacea	N/A
Completed	`NCT01555463` - Safety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular Rosacea	Phase 3
Active, not recruiting	`NCT03667222` - Topical Minocycline Gel for Inflammatory Lesions of Papulopustular Rosacea	Phase 2
Terminated	`NCT03564145` - A Long-Term Safety Study of S5G4T-1 in the Treatment of Papulopustular Rosacea	Phase 3
Completed	`NCT05150587` - Safety, Efficacy and Pharmacokinetics of Rifaximin in Patients With Moderate-to-severe Papulopustular Rosacea	Phase 2
Completed	`NCT03263273` - Study to Evaluate the Safety and Efficacy of Topical Minocycline Gel in Patients With Papulopustular Rosacea	Phase 2
Completed	`NCT05343455` - A Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea (MVOR-2)	Phase 3
Completed	`NCT01784133` - A Twelve Week Safety and Efficacy Study in Rosacea	Phase 2
Completed	`NCT01872715` - Patient Centered Outcomes in Rosacea: An Exploratory Multi-media Analysis of the Patient Experience on Oracea	Phase 4
Completed	`NCT05296629` - A Randomized, Double-Blind Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea.	Phase 3
Completed	`NCT05838170` - Study of TP-04 in Participants With Papulopustular Rosacea	Phase 2
Recruiting	`NCT06013371` - PDE4 Inhibition in Seborrheic Dermatitis and Papulopustular Rosacea	Phase 2
Recruiting	`NCT03864978` - Safety and Efficacy of Rifaximin in Patients With Papulopustular Rosacea and Positive Lactulose Breath Test	Phase 2
Completed	`NCT03079531` - Open Label Study to Assess the Effect of Secukinumab in Moderate to Severe Papulopustular Rosacea	Phase 1/Phase 2
Completed	`NCT01045551` - Open Label Pilot Study of Apremilast in Treatment of Rosacea	Phase 2
Completed	`NCT03448939` - A Study of S5G4T-1 in the Treatment of Papulopustular Rosacea	Phase 3
Completed	`NCT05675501` - Evaluation of Topical Encapsulated Benzoyl Peroxide on the Skin Microbiome and Skin Biophysical Properties	Phase 1
Withdrawn	`NCT03883945` - A Safety and Efficacy Study to Evaluate Rosacea	Phase 1/Phase 2